Now we are looking for viral deliverance when drug development is one of the world's most lucrative businesses, ownership of drug patents is disputed in endless court battles, and monopoly power often lets manufacturers set any price, no matter how extraordinary. A new cancer treatment can cost a half-million dollars, and old staples like insulin have risen manifold in price to thousands of dollars annually. .The prices that insurers pay for in-network services are typically much lower than the provider list prices. .The jury is still out on value-based health systems, and whether they can save any significant amount of money remains to be seen. The Congressional Budget Office issued a recent report outlining a number of issues and unintended consequences such as providing an incentive for providers to improve their "quality rankings" by avoiding sicker patients. Critics say that the system places a new burden on primary care doctors that would potentially punish providers financially for patients' bad health habits and behaviors. .Unless you are in poor health and need money to put food on the table or keep a roof over your head, these days it makes sense to delay starting benefits as long as you can. That's especially true if you're single and have limited retirement savings. If you claim Social Security too early, you could set yourself up for a reduced standard of living for the rest of your life. ."Because earnings are used to determine entitlement, the portion of earnings from jobs worked prior to legal authorization poses a substantial long-term liability to the Social Security Trust Fund," Cates says. In order to improve Social Security solvency, Congress is expected to consider cutting Social Security benefits, perhaps significantly, at some point in the future. "This policy that ‘pays benefits based on work while in the country illegally raises questions as to whether individuals who worked without authorization and committed document fraud will benefit at the expense of others who paid in under valid SSNs," Cates notes. .On Tuesday, Senators on the influential Finance Committee held a hearing titled "Examining the Proposed Medicare Part B Drug Demonstration." Dr. Patrick Conway testified before the full committee on the status of the controversial demonstration program, which was proposed by CMS earlier this year and has not yet been implemented. The program will test new payment strategies for hospitals and physicians who administer prescription drugs to Medicare beneficiaries receiving outpatient care. It is a new attempt by the Obama Administration to move away from a medical system that rewards volume of care and towards one that values high-quality care. .Higher-income beneficiaries. People with modified gross incomes of ,000 (individuals) or 0,000 (couples) in 2017 are required to pay higher Part B premiums, depending on income. .Members in the House have decided to offset the bill with a five-year delay of the Affordable Care Act's individual mandate. Those in the Senate have acknowledged that its chances of passing through their chamber are slim. Sen. Orrin Hatch (UT), Ranking Member of the Senate Finance Committee, said of the House's approach: "The House passes a law – they're very good at legislation – but it dies in the Senate. The Senate won't even bring it up." Meanwhile, Senate Majority Leader Harry Reid (NV) has said, "We're going to move forward in our own way." .For updates on the three bills endorsed by TSCL this week, follow the Legislative News or the Track Bills sections of our website. To view TSCL's full legislative agenda for the 115th Congress, click HERE.